Clonidine
- TRADE NAMES: Barclyd; Catapres (Boehringer Ingelheim); Catapresan; Daipres; Dixarit; Duraclon; Haemiton; Nexiclon; Nu-Clonidine; Sulmidine
- INDICATIONS: Hypertension
- CLASS: Adrenergic alpha-receptor agonist
- HALF-LIFE: 6–24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acebutolol, Alfuzosin, Amitriptyline, Amoxapine, Atenolol, Betaxolol, Captopril, Carteolol, Cilazapril, Clomipramine, Desipramine, Dexmethylphenidate, Diclofenac, Doxepin, Enalapril, Esmolol, Fosinopril, Imipramine, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Irbesartan, Levodopa, Levomepromazine, Lisinopril, Meloxicam, Metoprolol, Milnacipran, Nadolol, Nebivolol, Nortriptyline, Olmesartan, Oxprenolol, Penbutolol, Pericyazine, Pindolol, Propranolol, Protriptyline, Quinapril, Ramipril, Sotalol, Sulpiride, Timolol, Trandolapril, Triamcinolone, Tricyclic antidepressants, Trimipramine, Verapamil
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
